Trikafta’s U.S. record value is over $322,000 a yr. That’s almost 60 instances the annual wage of a minimal wage earner in Turkey, the place the federal government wished to import a generic model made in Argentina. Vertex sued and blocked it.
Vertex has introduced in $17 billion from Trikafta since 2019. An evaluation by researchers in Britain discovered {that a} yr’s provide of the drug might be manufactured for simply $5,700.
The corporate says it’s working to extend entry to the drug globally.
